CD274 and Decreased total neutrophil count: In an observational study, anti-PD-L1 immunotherapies were associated with neutropenia, autoimmune hemolytic anemia, and immune thrombocytopenia, as well as others with bicytopenias, showing congruency with the findings of our study, among multiple reports in the literature [11,12].